Prostate Cancer Canada invests in research that will uncover better diagnostic and treatment options, and towards providing comprehensive education and support services for those living with and affected by prostate cancer.
Prostate Cancer is the most common cancer in men; 1 in 8 Canadian men will be diagnosed with prostate cancer in their lifetime. Early detection saves lives. When detected early, the survival rate for prostate cancer is over 90%.
In agreement with prostate cancer experts, Prostate Cancer Canada advocates for a “smart screening” approach to early detection which takes a man’s personal risk into account. This involves getting a Prostate Specific Antigen (PSA) test at age 40 to establish a baseline number which is then incorporated into the man’s risk profile to determine when the next PSA test needs to occur.